Your email has been successfully added to our mailing list.

×
0 0 0 0 0 -0.00540540540540541 0 -0.0108108108108108
Stock impact report

World Health Organization Recommends INN for Thymosin Beta 4 as "timbetasin"

REGENERX BIOPHARMS INC (RGRX) 
NASDAQ:AMEX Investor Relations: regenerx.com/investors
Company Research Source: PR Newswire
ROCKVILLE, Md., Sept. 6, 2018 /PRNewswire/ -- RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that the recommended INN (International Nonproprietary Name) for Thymosin Beta 4 is timbetasin, as published by the World Health Organization (WHO). The term "INN" is an official name given to a new active pharmaceutical ingredient as prescribed by the WHO and is given for the classification of substances. Any drug substance that has the characteristics of "Thymosin beta 4" that will be developed as a pharmaceutical product in the future must use the name "timbetasin", a term requested by GtreeBNT.  The common name, "timbetasin," was designated according to the guidelines for WHO INN naming and has a symbolic meaning that can be associated with Thymosin Beta 4.An INN is basically given based on the structure of the compound and the mechanism of action Show less Read more
Impact Snapshot
Event Time:
RGRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for RGRX alerts
Opt-in for
RGRX alerts

from News Quantified
Opt-in for
RGRX alerts

from News Quantified